ITGB2 and cancer: However, the biological mechanisms of the interactions between TNXB-SDC4, THY1-(ITGAX+ITGB2), ICAM1-(ITGAX+ITGB2), and C3-(ITGAX+ITGB2) ligand-receptor pairs in cancer remain unclear and warrant further investigation.